Jazz Pharmaceuticals Submits Marketing Authorization Application to European ...

thumbnail

Trending Keywords   Jazz Pharmaceuticals • Solriamfetol • Excessive daytime sleepiness • European Medicines Agency • Pharmaceutical industry • Marketing Authorization Application • Obstructive sleep apnea


Jazz Pharmaceuticals Submits Marketing Authorization Application to European ... BioSpace (press release) (blog)

Published: Nov 09, 2018. DUBLIN, Nov. 9, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency for solriamfetol, a selective ...

Jazz Pharmaceuticals (JAZZ) Reports Submission of Marketing Authorization ... StreetInsider.com

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency for solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor, as a treatment to ...

Related Tweets

Currently showing only Tweets for US stories